Treatment of reflux disease during pregnancy and lactation

KALKAN, İsmail Hakkı; DAĞLI, Ülkü

Treatment of reflux disease during pregnancy and lactation

Ülkü DAĞLI, (Department of Gastroenterology, Başkent University School of Medicine, Ankara, Turkey)

İsmail Hakkı KALKAN (Clinic of Gastroenterology, Türkiye Yüksek İhtisas Training and Research Hospital, Ankara, Turkey)

Turkish Journal of Gastroenterology

0 0

Yıl: 2017 Cilt: 28 Sayı: 1 Sayfa Aralığı: 53 - 56 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Treatment of reflux disease during pregnancy and lactation

Öz:

Gastroesophageal reflux disease (GERD) is frequently seen during pregnancy. In the medical treatment of pregnant women with GERD, alginic acid and sucralfate can be used. Calcium- and magnesium-based antacids can also be used, particularly for patients with preeclampsia. In particular, ranitidine -a histamine-2 receptor blocker- is preferred. In the case of non-responsiveness to the abovementioned treatments, proton pump inhibitors (PPIs), except omeprazole, can be given considering the benefit-harm ratio for the mother and fetus after the first trimester. In cases with GERD during the lactation period, drugs having minimum systemic absorption, such as sucralfate and alginic acid, are preferable but there is no data

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Ho KY, Kang JY, Viegas OA. Symptomatic gastro-oesophageal reflux in pregnancy: a prospective study among Singaporean women. J Gastroenterol Hepatol 1998; 13: 1020-6. [CrossRef]
2. Ramu B, Mohan P, Rajasekaran MS, Jayanthi V. Prevalence and risk factors for gastroesophageal reflux in pregnancy. Indian J Gastroenterol 2011; 30: 144-7. [CrossRef]
3. Rey E, Rodriguez-Artalejo F, Herraiz MA, et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol 2007; 102: 2395-400.[CrossRef]
4. Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 2003; 32: 235-61. [CrossRef]
5. Richter JE. Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther 2005; 22: 749-57. [CrossRef]
6. Witten FP, King TM, Blake O. The effects of chronic gastrointestinal medications on the fetus and neonate. Obstet Gynecol 1981; 58(Suppl 5): 79-84.
7. Broussard CN, Richter JE. Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options? Drug Saf 1998; 19: 325-37. [CrossRef]
8. Tytgat GN, Heading RC, Müller-Lissner S, et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Aliment Pharmacol Ther 2003; 18: 291-301. [CrossRef]
9. Briggs GG, Freeman RY, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Baltimore, USA: William and Wilkins, 2002.
10. Strugala V, Bassin J, Swales VS, Lindow SW, Dettmar PW, Thomas EC. Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy. ISRN Obstet Gynecol 2012; 2012: 481870. [CrossRef]
11. Ranchet G, Gangemi O, Petrone M. Sucralfate in the treatment of gravid pyrosis. G Ital Obstet Ginecol 1990; 12: 1-16.
12. Berkovitch M, Elbirt D, Addis A, Schuler-Faccini L, Ornoy A. Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy. N Engl J Med 2000; 343: 445-6. [CrossRef]
13. Sørensen HT, Nielsen GL, Christensen K, Tage-Jensen U, Ekbom A, Baron J. Birth outcome following maternal use of metoclopramide. The Euromap study group. Br J Clin Pharmacol 2000; 49: 264-8. [CrossRef]
14. Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 2009; 360: 2528-35. [CrossRef]
15. Niebyl JR. Teratology and drug use during pregnancy and lactation. In: Scott JR, Isaia PD, Hammond C, et al., editors. Dansforths obstetrics and gynecology. 7th ed. Philadelphia: WB Saunders 1994: 225-44.
16. Ruigómez A, García Rodríguez LA, Cattaruzzi C, et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol 1999; 150: 476-81. [CrossRef]
17. Savarino V, Giusti M, Scalabrini P, et al. Famotidine has no significant effect on gonadal function in man. Gastroenterol Clin Biol 1988; 12: 19-22.
18. Morton DM. Pharmacology and toxicology of nizatidine. Scand J Gastroenterol Suppl 1987; 136: 1-8. [CrossRef]
19. Gill SK, O'Brien L, Koren G. The safety of histamine 2 (H2) blockers in pregnancy: a meta-analysis. Dig Dis Sci 2009; 54: 1835-8. [CrossRef]
20. Prilosec (product information). Wilmington, DE, USA: Astra- Zeneca, 2004.
21. Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G. Use of proton pump inhibitors during pregnancy and rates of major malformations. A meta-analysis. Dig Dis Sci 2002; 47: 1526-9. [CrossRef]
22. Prevacid (product information). Lake Forest, IL, USA: TAP Pharmaceutical, 2005.
23. Diav-Citrin O, Arnon J, Shechtman S, et al. The safety of proton pump inhibitors in pregnancy: a multicenter prospective controlled study. Aliment Pharmacol Ther 2005; 21: 269-75. [CrossRef]
24. Gill SK, O'Brien L, Einarson TR, Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol 2009; 104: 1541-5; quiz 1540, 1546.
25. Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med 2010; 363: 2114- 23. [CrossRef]
26. Physicians desk reference. 51st ed. Montvale (NJ): Medical Economics Company Inc., 1997.
27. Marshall JK, Thompson AB, Armstrong D. Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation. Can J Gastroenterol 1998; 12: 225-7. [CrossRef]
28. Plante L, Ferron GM, Unruh M, Mayer PR. Excretion of pantoprazole in human breast. J Reprod Med 2004; 49: 825-7.

APA	DAĞLI Ü, KALKAN İ (2017). Treatment of reflux disease during pregnancy and lactation. , 53 - 56.
Chicago	DAĞLI Ülkü,KALKAN İsmail Hakkı Treatment of reflux disease during pregnancy and lactation. (2017): 53 - 56.
MLA	DAĞLI Ülkü,KALKAN İsmail Hakkı Treatment of reflux disease during pregnancy and lactation. , 2017, ss.53 - 56.
AMA	DAĞLI Ü,KALKAN İ Treatment of reflux disease during pregnancy and lactation. . 2017; 53 - 56.
Vancouver	DAĞLI Ü,KALKAN İ Treatment of reflux disease during pregnancy and lactation. . 2017; 53 - 56.
IEEE	DAĞLI Ü,KALKAN İ "Treatment of reflux disease during pregnancy and lactation." , ss.53 - 56, 2017.
ISNAD	DAĞLI, Ülkü - KALKAN, İsmail Hakkı. "Treatment of reflux disease during pregnancy and lactation". (2017), 53-56.

APA	DAĞLI Ü, KALKAN İ (2017). Treatment of reflux disease during pregnancy and lactation. Turkish Journal of Gastroenterology, 28(1), 53 - 56.
Chicago	DAĞLI Ülkü,KALKAN İsmail Hakkı Treatment of reflux disease during pregnancy and lactation. Turkish Journal of Gastroenterology 28, no.1 (2017): 53 - 56.
MLA	DAĞLI Ülkü,KALKAN İsmail Hakkı Treatment of reflux disease during pregnancy and lactation. Turkish Journal of Gastroenterology, vol.28, no.1, 2017, ss.53 - 56.
AMA	DAĞLI Ü,KALKAN İ Treatment of reflux disease during pregnancy and lactation. Turkish Journal of Gastroenterology. 2017; 28(1): 53 - 56.
Vancouver	DAĞLI Ü,KALKAN İ Treatment of reflux disease during pregnancy and lactation. Turkish Journal of Gastroenterology. 2017; 28(1): 53 - 56.
IEEE	DAĞLI Ü,KALKAN İ "Treatment of reflux disease during pregnancy and lactation." Turkish Journal of Gastroenterology, 28, ss.53 - 56, 2017.
ISNAD	DAĞLI, Ülkü - KALKAN, İsmail Hakkı. "Treatment of reflux disease during pregnancy and lactation". Turkish Journal of Gastroenterology 28/1 (2017), 53-56.